121.93 USD
+2.18
1.82%
At close Updated Feb 6, 4:00 PM EST
Pre-market
After hours
121.56
-0.37
0.3%
1 day
1.82%
5 days
10.72%
1 month
12%
3 months
42.14%
6 months
53.49%
Year to date
14.54%
1 year
38.48%
5 years
70.29%
10 years
161.71%
 

About: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Employees: 75,000

0
Funds holding %
of 7,552 funds
0
Analysts bullish %
of 12 analysts
0
Positive news %
of 65 articles
Price charts implemented using Lightweight Charts™